Metap1 is known to act as tumor-promoting in cervical cancer, fibrosarcoma, and lung cancer (57, 58), and we recently discovered a role for Metap1 in promoting the sensitivity of breast cancer cells to phosphoinositide 3-kinase (PI3K) inhibition (19). This evidence concerns the gene METAP1 and cervical cancer.